Blueprint Medicines Corporation (BPMC): Price and Financial Metrics

BPMC POWR Grades

• BPMC scores best on the Value dimension, with a Value rank ahead of 61.51% of US stocks.
• The strongest trend for BPMC is in Quality, which has been heading down over the past 179 days.
• BPMC ranks lowest in Momentum; there it ranks in the 4th percentile.

BPMC Stock Summary

• BPMC's price/sales ratio is 21.88; that's higher than the P/S ratio of 93.42% of US stocks.
• Over the past twelve months, BPMC has reported earnings growth of -308.69%, putting it ahead of merely 6.31% of US stocks in our set.
• As for revenue growth, note that BPMC's revenue has grown -77.31% over the past 12 months; that beats the revenue growth of only 1.54% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to Blueprint Medicines Corp, a group of peers worth examining would be XBIT, IDYA, SGMO, DTIL, and XENE.
• BPMC's SEC filings can be seen here. And to visit Blueprint Medicines Corp's official web site, go to www.blueprintmedicines.com.

BPMC Valuation Summary

• In comparison to the median Healthcare stock, BPMC's price/earnings ratio is 55.89% lower, now standing at 16.1.
• Over the past 77 months, BPMC's price/earnings ratio has gone up 26.3.
• BPMC's EV/EBIT ratio has moved up 25.6 over the prior 77 months.

Below are key valuation metrics over time for BPMC.

BPMC Growth Metrics

The 2 year net income to common stockholders growth rate now stands at -110.11%.
• Its 2 year revenue growth rate is now at 335%.
• Its 5 year cash and equivalents growth rate is now at 207.83%.

BPMC's revenue has moved up $162,476,000 over the prior 70 months.

The table below shows BPMC's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	180.08	-298.653	-644.085
2021-09-30	107.165	-309.338	-411.067
2021-06-30	828.095	408.584	340.152
2021-03-31	809.143	370.585	325.122
2020-12-31	793.735	387.035	313.882
2020-09-30	811.161	366.939	333.218

BPMC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• BPMC has a Quality Grade of C, ranking ahead of 33.2% of graded US stocks.
• BPMC's asset turnover comes in at 0.067 -- ranking 297th of 682 Pharmaceutical Products stocks.
• OTLC, SGEN, and OCGN are the stocks whose asset turnover ratios are most correlated with BPMC.

The table below shows BPMC's key quality metrics over time.